Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Thermo Fisher to Acquire Life Technologies for USD 13.6 Billion

By BiotechDaily International staff writers
Posted on 22 Apr 2013
Print article
Thermo Fisher Scientific (Waltham, MA, USA) and Life Technologies Corporation (Carlsbad, CA, USA) have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies, creating enhanced capabilities for serving life science research, specialty diagnostics, and applied markets. The acquisition will take place for approximately USD 13.6 billion (plus the assumption of net debt at close—USD 2.2 billion as of yearend 2012).

The transaction will create a superior industry leader by building on both companies’ strengths for life sciences, such as proteomics, genomics, and cell biology. It will also strengthen technology and innovation leadership through complementary offerings that further broaden Thermo Fisher’s portfolio. Life Technologies provides innovative services and products (about 5,000 patents and licenses), offering a broad range of reagents, consumables, instruments, and systems. Life has an extensive offering of consumables for genomics, and molecular and cell biology and a range of technologies for bioproduction and forensics; it is also well known for its next-generation sequencing capability. These strengths, combined with Thermo Fisher’s leading offerings in analytical technologies and specialty diagnostics, create new convergence opportunities. The acquisition also enhances Thermo Fisher’s global reach. Life transacts more than half of its orders online through a highly regarded e-commerce platform. This leading capability, combined with Thermo Fisher’s extensive customer channels, creates a world-class infrastructure.


“This transaction enhances [...] our growth strategy: technological innovation, a unique customer value proposition, and expansion in emerging markets,” said Marc N. Casper, president and CEO of Thermo Fisher Scientific. Gregory T. Lucier, chairman and CEO of Life Technologies, said, “We look forward to joining forces with the outstanding team at Thermo Fisher, which shares our commitment to customers, employees, and the communities we serve.” Mr. Casper added, “Together we will be in an even stronger position to fulfill our company’s mission, which is to enable our customers to make the world healthier, cleaner, and safer.”

Related Links:

Thermo Fisher Scientific
Life Technologies



Print article

Channels

Genomics/Proteomics

view channel
Image: The first 3D map of the cancer-associated protein DCLK1 (doublecortin-like kinase 1), revealed how it functions (Photo courtesy of Walter and Eliza Hall Institute).

Kinase Domain Mutation Causes Protein Malfunction and Tumor Development

A team of chemical biologists has generated the first molecular map of the protein doublecortin kinase like domain 1 (DCLK1), a factor linked to more than 10% of gastric cancers that has also been found... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.